High-tech pharmaceutical products imports to Poland have exhibited robust growth from 2013 to 2023, with 2023 standing at 5.37 billion Euros in value. The year-on-year variations indicate a dynamic market, with notable increases such as 35.13% in 2020 and a steady 14.85% in 2023. The last five years have shown an impressive average annual growth rate (CAGR) of 16.5%.
From 2024 onwards, forecasts remain optimistic, projecting a continuation of this growth trajectory. The forecasted CAGR from 2024 to 2028, although slightly lower at 7.61%, is expected to yield a cumulative growth rate of 44.27% by 2028.
Future trends to watch for:
- Advances in pharmaceutical technology driving import increases.
- Regulatory changes impacting the import landscape.
- Emerging markets and new suppliers influencing market dynamics.
